Multiple sclerosis is associated with a variety of symptoms and functional deficits that result
in a range of progressive impairments and handicap. The symptoms, which contribute to …

Despite being acknowledged as an important component in the overall management of
multiple sclerosis, the relatively few evaluative studies in symptomatic treatment and …

Multiple sclerosis is a complex, heterogeneous disease associated with long-term disability.
Despite the availability of advanced disease-modifying and symptomatic therapies that may …

Multiple sclerosis (MS) is a chronic progressive disease which is the leading cause, after
road traffic accidents, of handicap in young subjects. The large range of symptoms …

Multiple sclerosis is a chronic, progressive, and disabling disease of the central nervous
system, for which no cure exists. By the advent of immune modulating pharmacological …

Multiple sclerosis is an increasingly prevalent disease, representing the leading cause of
non-traumatic neurological disease in Europe and North America. The most common …

Overall, there is an encouraging trend both in questioning our current practice and in
designing more scientifically sound trials incorporating new and more appropriate outcome …

Multiple sclerosis (MS) is a chronic, debilitating disease characterised by demyelination of
the nerves of the central nervous system that results in patients progressively losing the …

The importance of rehabilitation in the management of multiple sclerosis is now well
appreciated as is the need to demonstrate benefit through the appropriate use of …

The literature here reviewed indicates the importance of clinical and preclinical research in
addressing the impact of neurorehabilitation on MS disability, highlighting the need of further …